INTRODUCTION
Although H. pylori eradication is now the standard treatment of uncomplicated and bleeding peptic ulcers, its role in perforation remains controversial and these brackets of opinions pompously affect the decision making of the surgeon.
In 1983, the whole thinking regarding pathophysiology and management of this disease was revolutionized when Warren and Marshall reported Helicobacter pylori. They are recognized as a major causative factor of peptic ulcer disease and their eradication leads to cure of disease, i.e. better symptom control and fewer relapses. H. pylori infection is almost always present in the setting of active chronic gastritis and is present in most duodenal (>90%) and gastric 60 % to 90% in ulcer patients. 1 H. pylori can be diagnosed by mucosal biopsy, but noninvasive tests offer an effective screening tool and do not require an endoscopic procedure. It is now accepted that histologically confirmed chronic gastritis and duodenal ulceration is caused by H. pylori infection in over 90% of cases and H. pylori infection is responsible for 50% of gastric ulcer. 1 Complications of peptic ulcer disease such as bleeding, perforation, and stenosis occur in 3% of ulcer patient a year, and unless maintenance treatment is given, 82% of ulcer treated with H2 receptor antagonist relapse within one year.
Although the role of H. pylori in causation of duodenal and gastric ulcer is beyond doubt according to various studies, the role of H. pylori in various complications of PUD is not well understood. Various authors have reported an association of H. pylori infection with perforated peptic ulcer disease and opinion is still divided on this issue.
In this study the prevalence of H. pylori infection in patients presenting with perforated peptic ulcer disease in the emergency will be assessed. This will help the surgeon in deciding whether H. pylori eradication therapy should be offered to all patients with perforated PUD or it should be applied selectively. This study will also assess the sensitivity of stool antigen test for H. pylori detection in patients with perforated peptic ulcer.
METHODS
This observational study was conducted in the Department of General Surgery, Himalayan Institute of Medical Sciences (HIMS), Swami Ram Nagar, Dehradun, over a period of January 2013 to December 2013 and included 75 subjects who underwent exploratory laparotomy for peptic ulcer perforation.
The exclusion criteria were patients who were haemodynamically unstable at time of laparotomy or refused for H. pylori test. Subjects were recruited from patients presenting with a primary diagnosis of perforated peptic ulcer after obtaining written informed consent. Ethical clearance for the study was granted by ethics committee of the university.
The study tools included were Biopsy forceps, Rapid urease test (RUT) kit, Stool antigen kit. RUT was performed at the time of exploratory laparotomy. A biopsy of mucosa was taken from the antrum of the stomach and was placed into a medium containing urea and an indicator such as phenol red. Sterile biopsy forceps were introduced at site of ulcer perforation and mucosal biopsies were taken within 3cm of pylorus. Biopsy specimens were put in 10% formalin for histopathological examination. Stool antigen test was done by using standard kit available (standard diagnostics).
Diluent to be added to stool sample and with the help of the dropper 3 drops were added to the test device. This test was carried out only in patients with perforation in the postoperative period. Interpretation of test result was done 10-15 minutes for the presence of two color bands i.e. test band and control band. In this study out of the above-mentioned laboratory tests histological examination was considered gold standard.
The result data obtained was evaluated and studied by analytical method Pearson Chi square test to ascertain statistical significance and with software SPSS, version 20.
RESULTS
In this study, H. pylori infection was found to be present in 61% of these patients as detected by biopsy. The result of diagnostic tests for H. pylori in patients with perforated peptic ulcer disease is shown in Table 1 . Infection with H. pylori is almost universal in patients aged more than 70 years and maximum infection rate excluding this group was seen in 51-60 years age group as shown in Table 2 . Bateson at al reported strong association between H. pylori infection and current smoking while in this study the association of H. pylori infection with smoking in perforated peptic ulcer disease patients is not found to be significant. 13 Overall alcoholics have higher prevalence of peptic ulcer disease as reported by Parlet et al but as seen in this study history of alcohol intake doesn't impact infection with H. pylori. 14 Shipnen et al 1992, Grahm et al 1991 reported that H. pylori infection more common in lower socioeconomic status and author have reported similar results in this study amongst patients with perforation H. pylori infection is the same across the socioeconomic status (50% for lower socioeconomic group, 56% in the rest). 15, 16 The stool antigen test for detection of H. pylori was carried out in 20 out of 75 patients with perforated peptic ulcer and it was found to be negative for H. pylori for all the 20 patients. The sensitivity of stool antigen test in simple ulcer as reported in literature is in range of 88-100%. 17 However, no report is available on utilization of stool antigen test for detection H. pylori in complicated ulcer disease specially in postoperative setting.
Demonstration of H. pylori in peptic ulcer perforation using stool antigen test was found to be negative. The probable reason being that patients with perforated peptic ulcer pass stools approximately 5 days after surgery, having received antibiotics and proton pump inhibitors during this period which might render the stool sample negative for antigen. Secondly most patients after surgery from perforated peptic ulcer perforation pass loose stools in postoperative period or require enema which reduces the bacterial load and hinders positivity of tests. Based on the results of this study stool antigen test does not seem to be a feasible test in the surgical patient.
CONCLUSION
The prevalence rate of H. pylori infection in patients with perforated peptic ulcer is approximately 61%. In the Indian context patients presenting with perforation should be tested for infection with H. pylori utilizing a gastric antral mucosal biopsy taken at the time of operation for histological analysis and eradication therapy should be advised to all those who are found positive. Stool antigen test is not a good tool to asses H. pylori infection in patients with perforated peptic ulcer in the perioperative setting.
